Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 368 participants.
Also called NCT07295522
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 368 participants
- Sponsor
- IRCCS Policlinico S. Donato
- Registry
-
NCT07295522 -
2025-520660-18
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT07295522. Randomized; no masking; primary purpose treatment. Start 2026-03-31 (actual); primary completion 2027-06-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
- Acronym
- PopS-HF
- Condition
- Heart Failure
- Condition
- Acute Heart Failure
- Condition
- Heart Failure With Preserved Ejection Fraction (HFPEF)
- Condition
- Heart Failure With Mildly Reduced Ejection Fraction
- Intervention (Drug)
- Guideline-Directed Medical Therapy (GDMT)
- Lead sponsor
- IRCCS Policlinico S. Donato
- Collaborator
- Agenzia Italiana del Farmaco
Record details
- Record id
cardio:ct-nct07295522- Content hash
9b59b36d682543ec95a3537f353613704137797e5267fa8ea497bc597b939b48